Provided by Tiger Fintech (Singapore) Pte. Ltd.

Meiragtx Holdings Plc

8.66
-0.2400-2.70%
Volume:517.22K
Turnover:4.43M
Market Cap:696.68M
PE:-4.27
High:9.04
Open:8.98
Low:8.31
Close:8.90
52wk High:9.73
52wk Low:4.55
Shares:80.45M
Float Shares:31.70M
Volume Ratio:0.71
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0292
EPS(LYR):-2.1167
ROE:-379.53%
ROA:-42.42%
PB:235.36
PE(LYR):-4.09

Loading ...

MeiraGTx Holdings Is Maintained at Buy by Chardan Capital

Dow Jones
·
Nov 11

Top News Today/Canada: Barrick's Interim CEO Gets to Work

Dow Jones
·
Nov 11

REFILE-BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Tower Semiconductor, GlobalFoundries

Reuters
·
Nov 11

Eli Lilly Stock Rises 5% to Record High. It Signs Deal for MeiraGTx's Gene Therapy for Severe Eye Disease

Reuters
·
Nov 10

BUZZ-U.S. STOCKS ON THE MOVE-Instacart, Plug Power, Crypto stocks

Reuters
·
Nov 10

Shares of MeiraGTx Holdings Rise 11.5% on Collaboration With Eli Lilly for Rare Eye Disease Treatment

THOMSON REUTERS
·
Nov 10

MeiraGTx Showcases Advancements in Genetic Medicine with Late-Stage Clinical Pipeline and Manufacturing Capabilities

Reuters
·
Nov 10

MeiraGTx Announces Strategic Collaboration with Eli Lilly for Ophthalmology Gene Therapies

Reuters
·
Nov 10

MeiraGTx Enters Into Strategic Collaboration With Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology

THOMSON REUTERS
·
Nov 10

MeiraGTx Holdings Plc - to Receive $75 Mln Upfront and $400 Mln in Milestones

THOMSON REUTERS
·
Nov 10

MeiraGTx Holdings Plc - Grants Lilly Exclusive Rights to Aav-Aipl1 Program

THOMSON REUTERS
·
Nov 10

MeiraGTx Holdings PLC expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
Nov 07

MeiraGTx Holdings (NASDAQ:MGTX) Is Making Moderate Use Of Debt

Simply Wall St.
·
Oct 22

MeiraGTx CFO & COO Richard Giroux Reports Disposal of Common Shares

Reuters
·
Oct 22

MeiraGTx initiated with a Strong Buy at Raymond James

TIPRANKS
·
Oct 21

MeiraGTx Holdings plc President & CEO Alexandria Forbes Reports Disposal of Common Shares

Reuters
·
Oct 08

BRIEF-MeiraGTx Announces Two Posters At The European Society Of Gene And Cell Therapy (ESGCT) 2025 Annual Congress

Reuters
·
Oct 07

MeiraGTx Announces Promising New Clinical Study on Novel AAV Gene Therapy Capsids for Ocular Diseases at ESGCT 2025

Reuters
·
Oct 07

MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (Esgct) 2025 Annual Congress

THOMSON REUTERS
·
Oct 07

Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations to Drive Next Phase of Growth

Reuters
·
Oct 02